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Abstract
Background: The Passo Fundo Cohort Study (PFS) is a population-based longitudinal observational study of
pre-, peri-, and postmenopausal women that has been ongoing since 1995 in Passo Fundo, a city in southern
Brazil. This paper describes the rationale and design of the PFS and summarizes objectives and procedures that
have been updated during follow-up.
Methods/Design: Women in the PFS have been followed for a variety of diseases that are frequent in menopause.
Sampling was conducted in 154 randomly selected census divisions (geographical subdivisions of the city as defined
by the Brazilian Institute of Geography and Statistics). One block in each census division was chosen by lot and two
women were randomly selected for interview in each block. The first cycle, conducted between 1995 and 1997,
included a representative sample of 298 women aged 35 to 55 years. In the second cycle, conducted between
2001 and 2002, additional participants were enrolled based on the same sampling strategy used in 1995, for a
final sample of 358 women. In 2010, a third follow-up was initiated, when all 358 participants or their relatives
were located. Participants completed a standardized questionnaire on demographic and socioeconomic characteristics.
They also answered questions about lifestyle, medical and reproductive characteristics, sexual life, hormone therapy
and mental aspects by using validated instruments. Physical activity was assessed and anthropometric measurements,
blood sampling and pelvic ultrasound examination were performed. In the third cycle, bone mineral density by
dual-energy X-ray absorptiometry and abdominal fat and coronary artery calcium score by computed tomography
were also determined.
Discussion: The study findings provide relevant information to evaluate the association between menopausal status,
female aging and the risk of cardiovascular diseases, and bone health aspects in a representative sample of women
from southern Brazil.
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Background
Improvements in health care and sanitation have reduced
mortality from infectious diseases in developing countries.
As a consequence, non-communicable diseases, such as
diabetes and cardiovascular disease, are now the leading
cause of morbidity and mortality worldwide, with a huge
impact on health and society [1, 2]. In Brazil, an upper-
middle-income country, only a few observational studies
have examined non-communicable diseases, especially re-
garding women’s health [3]. In this respect, the Passo
Fundo Cohort Study (PFS) has been conducted for nearly
15 years, investigating pre-, peri-, and postmenopausal
women. This paper describes the rationale and design of
the PFS and summarizes objectives and procedures that
have been updated during follow-up.
The main objective of the first cycle of the PFS was to
investigate the prevalence of climacteric symptoms and
their association with transvaginal sonographic features
and hormone levels in pre- and perimenopausal women.
It also investigated lifestyle habits, socioeconomic status,
sexual activity, menstrual complaints, and hormone ther-
apy in this population.
In the second cycle, the main goal of the study was to
investigate the association of obesity, central adiposity,
and ovarian volume with menopausal status, taking into
account several confounding factors. In addition, the rela-
tionship between physical, psychological, and menopause-
related symptoms and minor psychiatric disorders was
also studied.
In the third cycle, the objective was to assess cardiovas-
cular risk among pre-, peri-, and postmenopausal women
through habitual physical activity, coronary artery calcium,
abdominal fat and anthropometric measurements.
Regarding the cohort design, the aim was to assess clin-
ical, hormonal, and metabolic features and bone mass in
these women over time in relation to cardiovascular risk
and prediction of cardiovascular events.
Methods/design
The design of the Passo Fundo Cohort Study (PFS)
The PFS is a prospective cohort study conducted in Passo
Fundo, a city in southern Brazil. The sample consists of
women in pre-, peri-, and postmenopause. Figure 1 shows
a flow chart of the three cycles of the study.
First cycle
From January 1996 to February 1997, participants were re-
cruited for the study. The sample for the first study was
selected from the 16,958 women between 35 and 55 years
of age living in Passo Fundo according to the 1991 census.
Women with an intact uterus and at least one period in
the previous 12 months were invited to participate. Sam-
pling was conducted in two stages. First, 154 geographical
subdivisions of the city, defined by the Brazilian Institute
of Geography and Statistics [4] as census divisions, were
randomly selected. One block in each census division
was chosen by lot and two women were randomly
selected for interview in each block according to the
Fig. 1 Cycles of the Passo Fundo Cohort Study (PFS). Year 1995–1996 (first cycle): baseline assessment of the original cohort. Year 2001–2002
(second cycle): baseline reassessment and cohort expansion to include 119 additional women aged 35-62 years. Year 2010–2011 (third cycle): first
reassessment of women from the second cycle. Continuous arrows indicate missing or dead/deceased women. Dotted arrow indicates added
women. Modified from Colpani et al. 2014 [33]
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following procedures: in all blocks, each corner was classi-
fied as A, B, C, or D, following the same order from left to
right and from bottom to top. To start the interviews, one
block was chosen per census division, and one corner per
block. Two women were then interviewed in each block.
When the drawn corner was A or B, the first woman
interviewed was chosen for blood sampling and ultra-
sound examination; when the drawn corner was C or D,
the second woman interviewed was chosen for examin-
ation. From the selected corner, the block was investigated
in a clockwise direction until an eligible participant was
found. Once found, the two nearby houses were excluded,
and the third one was screened. If there was more than
one eligible woman per household, the one with the most
recent birthday was selected for the interview. If the po-
tential participant was not at home, the interviewers
returned to the household on another day to interview
her. If the selected household was a building, only one
interview was performed; the floor and apartment for the
interview were also randomly selected. A loss was consid-
ered to have occurred when women refused to partici-
pate in the study or to undergo ultrasound examination
after three attempts by the interviewer. A sample of
302 women aged 35 to 55 years who had had at least
one period in the previous 12 months was randomly se-
lected. At the end of the first cycle (1995–1996), a rep-
resentative sample of 298 women was interviewed
(response rate 83.2 %).
Second cycle
A second home visit was conducted between July 2001 and
July 2002, when 239 women of the baseline cohort were lo-
cated and interviewed [5, 6]. The investigators searched for
information about first cycle participants with neighbors,
in electricity and water company databases, in medical re-
cords at Hospital São Vicente de Paulo, and at the Passo
Fundo University, the municipal health department, and
the Health Information Center (NIS/RS-SES). The reten-
tion percent was 80.2 %. Losses were classified as follows:
unwilling to participate (19 = 6.37 %), not found (21 = 7 %),
moved out of the city (15 = 5 %), and died (4 = 1.3 %).
In view of potential losses to follow-up and considering
an increase in population size, 120 additional women aged
35 to 62 years were randomly selected to ensure sufficient
statistical power for analysis. Of these, 119 were inter-
viewed (participation percent 99 %, final total sample of
358 participants). The new participants were randomly se-
lected based on the 175 census divisions defined in the
2000 IBGE census. Sixty new census divisions were chosen
by lot and one block was chosen per division, following the
same randomization procedures used in the first cycle. Eli-
gibility did not include menstrual criteria for this additional
sample of women, since some women from the first cycle
had already reached postmenopausal status.
Third cycle
In 2010, a third follow-up was initiated in order to assess
cardiovascular outcomes [7]. Every effort was made to lo-
cate each participant of the previous cycle. For that, contact
was made with close relatives, neighbors, and neighboring
households; in addition, we reviewed inpatient and out-
patient records at Hospital São Vicente and University of
Passo Fundo, municipal department of health records in
search of women registered to receive medication through
the public health system SUS, the city dental registry and
the city death records. We also ran an advertisement cam-
paign on two radio stations, Planalto and Uirapuru, reach-
ing 60 municipalities and around 30 thousand listeners per
day, and two television stations, RBS TV Passo Fundo and
UPF TV, reaching 85 municipalities. All 358 participants or
their relatives were located and information on the partici-
pant’s vital status was obtained for the period ending in No-
vember 2011.
Setting
Passo Fundo is a city located in Rio Grande do Sul, the
southernmost state of Brazil. The city has a current popu-
lation of approximately 184 000 inhabitants (data from the
2010 IBGE census) [8]. The economy is based primarily
on agriculture and business [8].
Population
The representative sample included in the PFS consists of
pre-, peri-, and postmenopausal women living in the urban
area of Passo Fundo, although, in the beginning of the
study, the sample was composed only of pre- and peri-
menopausal women. Menopausal status was determined
based on the characteristics of menses or time since amen-
orrhea: premenopause was defined as no change in men-
strual frequency or flow, and perimenopause was defined
as changes in menstrual frequency or flow in the 12 months
before the study; and postmenopause was defined as 12 or
more months of amenorrhea occurring naturally or be-
cause of surgical intervention, such as bilateral oophorec-
tomy. Questions such as “when was your last period?”,
“how is your menstrual flow?” and “ have you ever been
submitted to gynecological surgery (in which organ)?” were
asked. A “hysterectomy” category was created for women
who had previously undergone hysterectomy without bilat-
eral oophorectomy and whose menopausal status could
not be classified.
Eligibility criteria
The PFS was designed as a longitudinal study in order to
analyze pre-, peri-, and postmenopausal women. Initially,
eligible participants were women aged 35 to 55 years who
had at least one menstrual cycle in the past 12 months and
who were living in the urban area of Passo Fundo, Brazil.
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Exclusion criteria
Women who had undergone bilateral oophorectomy and/
or hysterectomy were excluded from the study. An eligible
participant was considered a loss if she refused to partici-
pate in the study after three attempts of having her accept
participation.
Sample size
In the first cycle, the sample size was based on a popula-
tion of 16,958 women between 35 and 55 years of age.
The sample size for prevalence studies was calculated
based on the assumption that 20 % of premenopausal and
perimenopausal women would have climacteric symp-
toms, with a 15 % error and 95 % CI. The sample size was
increased by an additional 10 % to account for potential
missing data, for a targeted sample size of 318 women.
For the second cycle, the sample size was estimated
based on population growth for year 2000. The estimated
population growth was 2.03 % per year between 1991-
1996, and 1.88 % per year between 1996 and 2000. There-
fore, the growth in this period was 17.7 %. Based on this
information, 54 women were randomly selected. Sixty-six
additional women were selected to cover potential follow-
up losses. The power of the study was thus maintained.
Ethical considerations
The PFS was approved by the institutional review board of
both Passo Fundo University and Hospital de Clínicas de
Porto Alegre. Written informed consent was obtained from
each participant. During data collection, care was taken to
ensure confidentiality of participants’ information.
Methods
A standardized questionnaire covering demographic char-
acteristics (age and self-reported skin color), education,
medical history, family history, reproductive history, sex-
ual activity (in the last three months), lifestyle/behavioral
factors, quality of life, medication/supplement inventory,
climacteric symptoms, and hormone therapy was applied.
More details regarding which items were included in each
cycle are shown in Table 1. In the first and second cycles,
participants were interviewed at home and examinations
were performed at Hospital São Vicente de Paulo. In the
third cycle, all measurements and interviews were con-
ducted at the hospital.
Training
Field training of students and health care professionals
was conducted by the PFS coordinators according to the
study protocol (interviewer guide). Intra and inter obser-
ver reliability was determined. All participants were thor-
oughly examined at baseline.
A pilot study was conducted in July 1995. The main ob-
jective of this pilot study was to test the agreement between
ultrasound operators; additional objectives were to probe
the participants’ understanding of questions and to monitor
adherence to hospital visits for collection of blood sam-
ples and ultrasound examination. Fifty-six premeno-
pausal women were randomly enrolled from 14 census
divisions. Two women were excluded due to total hys-
terectomy and bilateral oophorectomy. During the pilot
study, pelvic ultrasound was performed by two examiners,
resulting in 83 % agreement between them. Interviews
were tested for reliability and reproducibility. Interob-
server reliability for anthropometric and blood pressure
measurements was also verified by repeated measure-
ments during the first set of consultations (R values were
higher than 0.90, p < 0.05).
Study variables
Education
Educational attainment was assessed through the num-
ber of years of successful formal education, described as
years at school.
Socioeconomic status
Socioeconomic status was assessed using an instrument
developed by the Brazilian Association of Market Re-
search Institutes (Associação Brasileira de Institutos de
Pesquisa de Mercado, ABIPEME) [9]. It classifies indi-
viduals into five socioeconomic groups: A, B, C, D, and E,
where A represents the highest socioeconomic level. This
classification is based on 10 selected variables: level of
education of the household head, number of cars, having
a washing machine and videotape recorder, having a vac-
uum cleaner, having a refrigerator, number of color televi-
sions, number of bathrooms, number of radios, and being
able to pay a housekeeper. The participants were classified
as working or not working, and by employment status
(employer, employee, self-employed, housemaker).
Alcohol intake
From the second cycle onward, alcohol consumption was
determined by self-reported alcohol intake (non-drinker
or former drinker). In 2001 and 2010, participants were
asked what type of alcohol (wine, beer, spirits) they con-
sumed and frequency of consumption.
Smoking
Smoking status was also assessed from the second cycle
onward. Participants were considered smokers if they
smoked more than five cigarettes per day [10]. Subse-
quently, in 2010, the amount of smoking and age at
smoking onset and cessation were assessed in detail
using a self-administered questionnaire. Former smokers
were defined as individuals who reported having quit
smoking and, in this case, they were also asked how long
it had been since they quit smoking. No minimum time
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since smoking cessation was employed in the definition
of former smokers. Because there was no specific ques-
tion on occasional smoking, occasional smokers were
grouped as current or former smokers if they met the
aforementioned criteria.
Gynecological data
Women were asked questions about age at menarche,
delivery history (vaginal delivery, cesarean delivery,
miscarriage), previous gynecological surgery, and sex-
ual activity (in the last three months). Use of oral
contraceptive, hormone therapy, estrogen, estrogen
plus progestin or tibolone was verified by asking the
participants to show the medication box or the physi-
cian’s prescription and categorized according to dur-
ation (in years) of use.
Menopausal symptoms
The Kupperman Menopausal Index was used to evaluate
menopausal symptoms [11]. It is a numerical index that
ranks menopausal symptoms based on the sum of scores
attributed to variables according to the presence and in-
tensity of symptoms. Scores range from 0 to 3, where 0 =
absent, 1 =mild, 2 =moderate, and 3 = intense symptoms.
Weighted values were assigned to the variables, as follows:
hot flashes (4), night sweats (4), vaginal dryness (3), in-
somnia (2), memory (2), nervousness (2), depression (1),
dizziness (1), fatigue (1), and headache (1).
Clinical history
Blood draw
At baseline, blood was collected from a subsample of 140
women. Blood samples were collected on the same day of
the ultrasound examination, between 4 and 6 PM. The
Table 1 Questionnaires and clinical information assessed in the PFS
Variable Method Cycle (year)
Clinical and demographic characteristics Self-report 1995/2001/2010
Physical activity
Self-report 1995
Modifiable Activity Questionnaire (MAQ) [19] 2001
International Physical Activity Questionnaire (IPAQ) [22] 2010
Pedometer 2010
Quality of life
Women’s Health Questionnaire (WHQ) [12] 2010
12-Item Health Survey (SF-12) [14] 2010
Menopausal symptoms
Kupperman Menopausal Index [11] 1995/2001/2010
Psychiatric disorders
20-Item Self-Reporting Questionnaire (SRQ-20) [17] 2001/2010
Blood samples
Hormones 1995/2001/2010
Cholesterol (mg/dL) (mmol/L) 2001/2010
Triglycerides (mg/dL) (mmol/L) 2001/2010
Glucose (mg/dL) (mmol/L) 2001/2010
Insulin (mU/L) 2001/2010
DNA samples 2010
Anthropometric measurements
Body mass index 1995/2001/2010
Waist circumference 2001/2010
Waist-to-hip ratio 2001/2010
Skinfolds Calipers 2001
Diagnostic imaging
Pelvic Ultrasound 1995/2001
Densitometry 2010
Computed tomography 2010
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day of the reproductive cycle was recorded on this occa-
sion; therefore, tests were performed on any day of the
menstrual cycle. In the second and third study cycles,
blood samples were collected from all participants be-
tween 8 and 10 AM after an overnight fast of 10 to 12 h.
In the third study cycle (2010), blood was also drawn and
stored at −80 °C for future hormone studies, and DNA
was extracted from blood samples and stored for future
genetic and molecular analysis.
Blood pressure measurements
Standardized blood pressure measurements were per-
formed twice, using the same calibrated mercury manom-
eter. The average of two assessments was used in the
analysis. Hypertension was identified by systolic blood
pressure greater than or equal to 140 mm Hg or diastolic
blood pressure greater than or equal to 90 mm Hg.
Hypertension
At baseline, hypertension was assessed by asking about
previous diagnosis of hypertension and measuring blood
pressure during the home interview. In the second and
third cycles, the question about previous diagnosis was
asked again and blood pressure was measured at the clinic.
Family history of hypertension (parents and grandparents)
was investigated from the second cycle (2001) onward.
Dyslipidemia
In the three cycles, self-reported hypercholesterolemia and
use of anti-cholesterol drugs were used to define dyslipid-
emia. Blood tests were also performed to measure choles-
terol and triglycerides levels.
Diabetes
Diabetes was determined by self-report, use of antidiabetic
drugs, or a fasting blood glucose level of 126 mg/dL or
higher. Metabolic syndrome was defined as the presence
of at least three of the following components: waist cir-
cumference greater than 88 cm, HDL-c level less than
50 mg/dL, TG level of 150 mg/dL or higher, blood pres-
sure greater than or equal to 130/85 mmHg, and glucose
level of 100 mg/dL or higher.
Quality of life
Quality of life was assessed in the third cycle (2010) using
the Women’s Health Questionnaire (WHQ) [12]. The
WHQ consists of 36 items divided into nine domains: de-
pressed mood, somatic symptoms, memory/concentra-
tion, anxiety/fears, sexual behavior, vasomotor symptoms,
sleep problems, menstrual symptoms, and attractiveness.
A score of 0 (zero) indicates good health status, a score of
50 % indicates regular health status, a score between 50
and 100 % indicates low health status, and a score of
100 % indicates poor health status.
The 12-Item Short Form Health Survey (SF-12), a short-
ened validated version of the 36-Item Short Form Health
Survey (SF-36), was also used as a tool to assess quality of
life in this population. It is a generic questionnaire, and
scores also range from 0 to 100 %. The SF-12 is derived
from the functional health and well-being domain of the
SF-36 (physical functioning, role limitations due to phys-
ical health problems, bodily pain, general health, vitality,
social functioning, role limitations due to emotional prob-
lems, and mental health) [13, 14].
Psychiatric disorders
From the second cycle onward, the use of medications for
insomnia, anxiety, and depression was investigated. In the
three cycles, psychiatric disorders were assessed using the
20-Item Self-Reporting Questionnaire (SRQ-20). The
SRQ-20 was developed by the World Health Organization
to screen for common mental disorders in primary health
care settings, and a version of this instrument has been
validated for use in Brazil. The questionnaire consists of
questions with yes/no answers about symptoms such as
sadness, irritability, headache, pleasure in daily activities,
crying frequently, decision-making, appetite, sleep disturb-
ance, lack of concentration, sense of usefulness, and fa-
tigue. It is used to screen for minor psychiatric disorders,
and a score of 8 or higher indicates a risk of psychiatric
disorders [15–17].
Physical activity
From the second cycle onward, physical activity was
assessed using structured questionnaires. In the second
cycle (2001), physical activity was assessed using a pre-
viously tested, standardized questionnaire for each type
of physical activity, the Modifiable Activity Question-
naire (MAQ), and metabolic equivalents and total cal-
oric expenditure were calculated [18]. Participants were
asked about the type and frequency of the activity per-
formed and time spent standing and sitting. The prac-
tice of sports after 18 years of age and in the last year
was also evaluated by collecting information on the fre-
quency and duration (in minutes) of each activity. Par-
ticipants who reached an energy expenditure of at least
1000 kcal/week (approximately 3.5 h per week in activ-
ities such as walking, climbing stairs, swimming, play-
ing sports, and yard work) were considered physically
active, while all others were classified as physically in-
active [19, 20].
In the third cycle (2010), the International Physical Ac-
tivity Questionnaire (IPAQ) was used. This instrument
was developed to facilitate the cross-national assessment
of physical activity and inactivity. The short-form ques-
tionnaire (IPAQ-SF) was used to evaluate self-reported
physical activity at four intensity levels (vigorous-intensity
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activity, moderate-intensity activity, walking, and sitting)
over the last seven days [21, 22].
Pedometer
In the third cycle (2010), habitual physical activity was
assessed using a digital pedometer (BP 148; TechLine, São
Paulo, SP, Brazil) [7]. The instrument records the number
of steps taken per day for seven days. The mean number
of steps was calculated by the ratio between the sum of
the daily totals and the number of days the pedometer
was used [23]. The device was individually configured ac-
cording to the participant’s weight (kg) and average step
length (distance between the heels in cm). Each partici-
pant was given a pedometer and instructed on how to
properly use the device. Participants were also provided
with a step-recording diary, where they were asked to rec-
ord the total daily number of steps and the time they put
on (wake-up time) and took off (before going to bed) the
pedometer. Participants were also instructed to go about
their usual activities and to remove the pedometer while
showering or sleeping and at the end of each day.
Anthropometric measurements
At baseline, weight and height measurements were per-
formed on the same day as blood collection and/or ultra-
sound examination. Measurements were taken without
shoes and heavy clothing. Weight was measured using a
mechanical scale (Filizola®, Brazil) and height was mea-
sured using a stadiometer coupled to the scale.
In the second and third cycles, anthropometric mea-
surements were performed in duplicate and included body
weight, height, waist circumference (measured at the mid-
point between the lower rib margin and the iliac crest,
perpendicular to the long axis of the body, with the par-
ticipant standing balanced on both feet, approximately
20 cm apart, with arms hanging freely), hip circumference
(widest circumference over the buttocks), and waist-to-hip
ratio (waist circumference divided by hip circumference).
Body mass index was calculated as weight in kilograms di-
vided by the square of height in meters (kg/m2) and cate-
gorized as < 25.0, 25.0–29.9, and ≥ 30.0 kg/m2 [24]. All
measurements were taken without shoes and heavy cloth-
ing. Interobserver reliability for anthropometric measure-
ments was verified by repeated measurements during the
first round of consultations.
Skinfolds
In the second cycle, skinfold thicknesses (mm) at the tri-
ceps, suprailiac, and subscapular were measured using skin-
fold calipers (Scientific CESCORF, RS, Brazil – similar to
the Harpenden model) to the nearest 0.2 mm. Values were
the mean of three measurements for each skinfold. The
percentage of total body fat was calculated by the Faulkner
formula: percent total body fat = (triceps + subscapular +
suprailiac + abdominal skinfolds × 0.153) + 5.783 [25].
Assays
At baseline, blood was assayed for 17-beta-estradiol
(E2), luteinizing hormone (LH), follicle-stimulating hor-
mone (FSH), sex hormone-binding globulin (SHBG),
and thyrotropin-stimulating hormone (TSH). E2 was
measured using a solid-phase radioimmunoassay kit
(Coat-A-Coat kit; Diagnostic Products Corporation, Los
Angeles, CA, USA), with a sensitivity of 20.0 pg/mL. FSH
and LH were measured by a solid-phase immunoradio-
metric assay (MAIAclone; Biodata Diagnostics, Rome,
Italy), with sensitivity of 0.25 mIU/mL. SHBG and TSH
were measured by a solid phase chemiluminescent immu-
nometric assay using the DPC Immulite kit (Diagnostic
Products Corporation), with sensitivity of 0.2 nmol/L and
0.002 IU/mL, respectively.
Total cholesterol, high-density lipoprotein cholesterol
(HDL-c), triglyceride (TG), and glucose levels were deter-
mined by a colorimetric enzymatic method (Architect
C800 System; Abbott Laboratories, Abbott Park, IL, USA).
Low-density lipoprotein cholesterol (LDL-c) was deter-
mined indirectly using the following formula: LDL-c = total
cholesterol − (HDL-c + TG/5) [26].
Ultrasound
Transvaginal ultrasound was performed with a Toshiba-
Tosbee apparatus (Toshiba Corporation, Tokyo, Japan)
using a 5.0 MHz transvaginal probe. The maximum trans-
verse (D1), anteroposterior (D2), and longitudinal (D3) di-
ameters of the ovary were measured with electronic
calipers. Ovarian volume was calculated using the follow-
ing formula: volume =D1 ×D2 ×D3 × 0.523. Ovarian cyst
was defined as a lesion with its largest diameter measuring
at least 25 mm [27]. The examinations were performed
in different phases of the menstrual cycle. Cycle phases
were classified as follicular (days 1–10), periovulatory
(days 11–17), and luteal (day 18 and later). The associ-
ation of ovarian volume with menstrual cycle phase was
analyzed to minimize any potential bias resulting from
the effect of cycle phase on ovarian volume [27–29].
At baseline, all ultrasound examinations were per-
formed by the same examiner. In the second cycle
(2001), examinations were also performed by a single
examiner and the interobserver correlation coefficient
was calculated by comparing results of each case between
the first- and second-cycle examiners. Reproducibility of
the ovarian volume measurement was evaluated using the
intraclass correlation coefficient to calculate the level of
agreement with a second observer. Ovarian volume meas-
urement achieved excellent reproducibility, with an intra-
class correlation coefficient of 0.957 (95 % CI 0.883–0.94)
Oppermann et al. Women's Midlife Health  (2015) 1:12 Page 7 of 9
for the right ovary and 0.982 (95 % CI 0.940–0.994) for
the left ovary.
Densitometry
In the third cycle (2010), bone mineral density was
assessed in the lumbar spine (L1-L4), femoral neck, and
proximal total femur by dual-energy X-ray absorpti-
ometry (Lunar Prodigy Advance DXA System; GE Med-
ical Systems, Milwaukee, WI, USA) in all participants.
The results were expressed in g/cm2 and estimated z-
and t-scores. All measurements were performed in the
Division of Radiology at Hospital São Vicente de Paulo.
Computed tomography (CT)
The coronary artery calcium score was assessed by chest
CT using a 128-channel multidetector CT scanner (Defin-
ition; Siemens Medical Systems, Erlangen, Germany) at
Hospital São Vicente de Paulo. The same radiologist read
all CT scans at a Siemens Workstation (Leonardo 4.1).
The average Agatston score was used in all analyses [30].
Subcutaneous and visceral fat areas were measured on a
cross-sectional scan obtained at the umbilicus (L3-L4) as
previously described [31].
Mortality data
In the third cycle (2010), medical records were reviewed
to collect information on age at death, date and cause of
death. The causes of death were coded according to the
International Classification of Diseases, 10th revision [32].
Discussion
The study findings provide relevant information on health
issues in midlife women and allow us to evaluate the asso-
ciation between menopausal status, aging in women and
the risk of metabolic comorbidities and cardiovascular dis-
eases in a representative sample of women from southern
Brazil. Key publications to date are summarized in Table 2.
Abbreviations
ABIPEME: Brazilian Association of Market Research Institutes; BMD: Bone
mineral density; CAC: Coronary calcium score; CT: Computed tomographic
scanning; CV: Cardiovascular; DXA: Dual-energy X-ray absorptiometry; E2:
17-beta-estradiol; FSH: Follicle-stimulating hormone; HDL-c: High-density
lipoprotein cholesterol; HT: Hormone therapy; IBGE: Brazilian Institute of
Geography and Statistics; IPAQ: International Physical Activity Questionnaire;
LDL-c: Low-density lipoprotein cholesterol; LH: Luteinizing hormone;
MAQ: Modifiable Activity Questionnaire; NCDs n: Non-communicable
diseases; NIS/RS-SES: Center for Health Information; PFS: Passo Fundo Cohort
Study; SF-12: 12 Item Health Survey; SF-36: Short Form Health Survey -36;
SHBG: Sex hormones binding globulin; SRQ-20: Self-Reporting Questionnaire;
Table 2 Main results of the PFS
Author, year Study design N participants Objective Conclusion
Oppermann et al. 2003 [33] Cross-sectional 98 To evaluate the relationship between
ovarian volume and age, hormone
levels, obesity, and menstrual cycle
phase in pre- and perimenopausal
women.
Ovarian volume was smaller in pre- and
perimenopausal women aged 40 years
or older compared with younger women.
Bastos et al. 2006 [5] Cross-sectional 273 To investigate the association of
smoking, parity, BMI, oral contraceptive
use, and hormone therapy with ovarian
volume in pre-, transition, and
postmenopausal women.
Obesity was positively related to ovarian
volume, menopausal status, and age.
Use of contraception was associated
with reduced ovarian volume.
Donato et al. 2006 [6] Cross-sectional 358 To investigate the association between
menopausal status and central adiposity
measured by two different cutoffs of
waist circumference and waist-to-hip ratio.
Postmenopausal women were at greater
risk of having central adiposity (waist
circumference and waist-to-hip ratio)
than premenopausal women.
Oppermann et al. 2012 [15] Cross-sectional 324 To identify the prevalence of physical,
psychological, and menopause-related
symptoms and their association with
minor psychiatric disorders in pre-,
peri-, and postmenopausal women.
Low level of education, memory loss,
irritability, and menopausal transition
were risk factors for positive findings
in screening for minor psychiatric
disorders.
Colpani et al. 2012 [7] Cross-sectional 292 To assess pedometer-determined
habitual physical activity in a Brazilian
cohort of pre-, peri-, and postmenopausal
women and its effect on anthropometric
measurements and cardiovascular risk
factors.
Walking 6,000 or more steps daily was
associated with a decreased risk of CVD
and DM in middle-aged women,
regardless of menopausal status.
Colpani et al. 2014 [34] Cross-sectional 292 To compare two methods of assessing
physical activity in pre-, peri-, and
postmenopausal women.
The agreement (k = 0110; p = 0.007)
and correlation (rho = 0.136, p = 0.02)
between the IPAQ-SF and the
pedometer were weak.
Colpani et al. 2014 [35] Longitudinal 358n To assess mortality rate, causes of death,
and associated risk factors in climacteric
women.
CVD was an important cause of death in
this cohort. DM and/or central adiposity
were associated with all-cause mortality.
BMI body mass index, CVD cardiovascular disease, DM diabetes mellitus, IPAQ-SF International Physical Activity Questionnaire-Short Form
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TG: Triglyceride; TSH: Thyrotrophin stimulating hormone; WC: Waist
circumference; WHQ: Women’s Health Questionnaire; WHR: Waist-to-hip ratio.
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